CDK14
Official symbol: | CDK14 |
Full name: | cyclin dependent kinase 14 |
Location: | 7q21.13 |
Also known as: | PFTK1, PFTAIRE1 |
Entrez ID: | 5218 |
Ensembl ID: | ENSG00000058091 |
Summary: | PFTK1 is a member of the CDC2 (MIM 116940)-related protein kinase family (Yang and Chen, 2001 [PubMed 11313143]).[supplied by OMIM, Mar 2008] |
|
Overall distribution
|
|
Tissue specific distribution
|
|
|
|
|
|
|
|
|
|
Overall distribution
|
|
Tissue specific distribution
|
|
Gscore (Amp): | 0.00 | Gscore (Del): | 0.00 |
|
|
|
|
|
|
|
|
Overall distribution
|
|
Tissue specific distribution
|
|
|
|
|
|
|
|
|
|
Overall
|
|
Tissue specific
|
|
Total fusion occurrence: | 14 (Driver) |
|
|
Fusions detected in 10 cancer type(s) |
|
|
|
|
|
Functional class: | Kinase (protein kinase) |
JensenLab PubMed score: | 25.44 (Percentile rank: 51.38%) |
PubTator score: | 20.46 (Percentile rank: 52.68%) |
Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |